Bath Savings Trust CO Gilead Sciences, Inc. Transaction History

Bath Savings Trust CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 01, 2019	SELL	$61.87 - $69.38 $205,099 - $229,994	-3,315 Closed	0 $0
Q1 2019 Apr 02, 2019	SELL	$62.53 - $70.05 $3,126 - $3,502	-50 Reduced 1.49%	3,315 $216,000
Q4 2018 Jan 04, 2019	SELL	$60.54 - $79.0 $70,831 - $92,430	-1,170 Reduced 25.8%	3,365 $211,000
Q3 2018 Oct 05, 2018	SELL	$71.28 - $78.92 $47,757 - $52,876	-670 Reduced 12.87%	4,535 $350,000
Q2 2018 Jul 05, 2018	SELL	$64.88 - $75.68 $165,119 - $192,605	-2,545 Reduced 32.84%	5,205 $369,000
Q1 2018 Apr 03, 2018	SELL	$72.84 - $88.8 $45,525 - $55,500	-625 Reduced 7.46%	7,750 $584,000
Q4 2017 Jan 10, 2018	BUY	$71.15 - $83.52 $6,759 - $7,934	95 Added 1.15%	8,375 $600,000
Q3 2017 Oct 02, 2017	BUY	$72.11 - $85.47 $597,070 - $707,691	8,280	8,280 $671,000

1,880

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Bath Savings Trust CO, based on Form 13F filings with the SEC.

Stay updated on Bath Savings Trust CO with notifications on news.